Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Morlock

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
The Lancet. Oncology|February 17, 2019
Patient-reported outcomes following enzalutamide or placebo in men with non-metastatic, castration-resistant prostate cancer (PROSPER): a multicentre, randomised, double-blind, phase 3 trialBertrand Tombal, Fred Saad, David Penson, et al.
Rheumatology and Therapy|October 18, 2016
Disease Control, Health Resource Use, Healthcare Costs, and Predictors in Gout Patients in the United States, the United Kingdom, Germany, and France: A Retrospective AnalysisRobert Morlock, Pierre Chevalier, Laura Horne, et al.
Neurogastroenterology and Motility|August 19, 2024
Treatment for chronic idiopathic constipation: Use and satisfaction from a nationwide survey of US participantsBrian E Lacy, Yanqing Xu, Douglas C A Taylor, et al.
Neurogastroenterology and Motility|September 3, 2024
Burden of illness and treatment attitudes among participants meeting Rome IV criteria for irritable bowel syndrome: A nationwide survey in the United StatesBrian E Lacy, Yanqing Xu, Douglas C A Taylor, et al.
BMJ Open|August 30, 2019
Gout and the risk of advanced chronic kidney disease in the UK health system: a national cohort studyAustin G Stack, Michelle Elizabeth Johnson, Betina Blak, et al.
Journal of Cataract and Refractive Surgery|March 24, 2026
Evaluation of spectacle independence with the Dutch Patient-Reported Spectacle Independence QuestionnaireNicolaas J Reus, Fallon van Dorst, Marjolein J C Kooijman-de Groot, et al.
Breast Cancer Research and Treatment|February 6, 2025
Patient preferences for CDK4/6 inhibitor treatments in HR+/HER2- early breast cancer: a discrete choice survey studyErica L Mayer, Mary Lou Smith, Annie Guérin, et al.
European Urology|April 28, 2020
Effect of Enzalutamide plus Androgen Deprivation Therapy on Health-related Quality of Life in Patients with Metastatic Hormone-sensitive Prostate Cancer: An Analysis of the ARCHES Randomised, Placebo-controlled, Phase 3 StudyArnulf Stenzl, Curtis Dunshee, Ugo De Giorgi, et al.
BMC Rheumatology|April 3, 2019
Incident gout and chronic Kidney Disease: healthcare utilization and survivalDena H Jaffe, Alyssa B Klein, Arriel Benis, et al.
Innovations in Clinical Neuroscience|April 6, 2022
Using Artificial Intelligence-based Methods to Address the Placebo Response in Clinical TrialsErica A Smith, William P Horan, Dominique Demolle, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
The Lancet. Oncology|February 17, 2019
Patient-reported outcomes following enzalutamide or placebo in men with non-metastatic, castration-resistant prostate cancer (PROSPER): a multicentre, randomised, double-blind, phase 3 trialBertrand Tombal, Fred Saad, David Penson, et al.
Rheumatology and Therapy|October 18, 2016
Disease Control, Health Resource Use, Healthcare Costs, and Predictors in Gout Patients in the United States, the United Kingdom, Germany, and France: A Retrospective AnalysisRobert Morlock, Pierre Chevalier, Laura Horne, et al.
Neurogastroenterology and Motility|August 19, 2024
Treatment for chronic idiopathic constipation: Use and satisfaction from a nationwide survey of US participantsBrian E Lacy, Yanqing Xu, Douglas C A Taylor, et al.
Neurogastroenterology and Motility|September 3, 2024
Burden of illness and treatment attitudes among participants meeting Rome IV criteria for irritable bowel syndrome: A nationwide survey in the United StatesBrian E Lacy, Yanqing Xu, Douglas C A Taylor, et al.
BMJ Open|August 30, 2019
Gout and the risk of advanced chronic kidney disease in the UK health system: a national cohort studyAustin G Stack, Michelle Elizabeth Johnson, Betina Blak, et al.
Journal of Cataract and Refractive Surgery|March 24, 2026
Evaluation of spectacle independence with the Dutch Patient-Reported Spectacle Independence QuestionnaireNicolaas J Reus, Fallon van Dorst, Marjolein J C Kooijman-de Groot, et al.
Breast Cancer Research and Treatment|February 6, 2025
Patient preferences for CDK4/6 inhibitor treatments in HR+/HER2- early breast cancer: a discrete choice survey studyErica L Mayer, Mary Lou Smith, Annie Guérin, et al.
European Urology|April 28, 2020
Effect of Enzalutamide plus Androgen Deprivation Therapy on Health-related Quality of Life in Patients with Metastatic Hormone-sensitive Prostate Cancer: An Analysis of the ARCHES Randomised, Placebo-controlled, Phase 3 StudyArnulf Stenzl, Curtis Dunshee, Ugo De Giorgi, et al.
BMC Rheumatology|April 3, 2019
Incident gout and chronic Kidney Disease: healthcare utilization and survivalDena H Jaffe, Alyssa B Klein, Arriel Benis, et al.
Innovations in Clinical Neuroscience|April 6, 2022
Using Artificial Intelligence-based Methods to Address the Placebo Response in Clinical TrialsErica A Smith, William P Horan, Dominique Demolle, et al.
Pageof 5